Actively Recruiting

Age: 18Years +
FEMALE
NCT06760923

Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression

Led by Xiangya Hospital of Central South University · Updated on 2025-01-07

240

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational study is to determine the urinary proteomic characteristics in women with and without ovarian cancer. The main questions it aims to answer are: 1. What is the difference in urinary protein composition between patients with ovarian cancer and those without it? 2. Can these differences in urinary protein composition aid in the diagnosis of ovarian cancer? 3. Are urinary protein markers associated with tumor burden in urine samples from patients with ovarian cancer? 4. Can urinary protein markers be used for disease surveillance in ovarian cancer patients?

CONDITIONS

Official Title

Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female patients in the gynecological ward for surgical treatment.
  • Initial diagnosis of "pelvic mass" or "malignant ascites" may be considered as ovarian cancer; Or the initial diagnosis of "ovarian cyst", "hydrosalpinx", "uterine fibroids" or "uterine adenomyosis" are considered as gynecological non-malignant diseases.
  • Over 18 years of age.
  • Voluntary participation and signing of informed consent.
Not Eligible

You will not qualify if you...

  • Study participants with a prior history of malignant tumors.
  • Study participants with prior chronic kidney disease or renal insufficiency.
  • Study participants who have received or are receiving treatment for primary disease.
  • Study participants whose pathological diagnosis was not clear.
  • Study participants who withdraw informed consent and request withdrawal.
  • Study participants unable to provide a qualified urine sample.
  • Situations in which the researcher considers it necessary to withdraw from the study.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Xiangya Hosipital of Central South University

Changsha, Hunan, China, 410008

Actively Recruiting

Loading map...

Research Team

Y

Yu Zhang, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression | DecenTrialz